Global Mobile Gamma Cameras Market By Product Type, By Application, By End User, By Region & Segmental Insights Trends and Forecast, 2024 – 2034

  • Industry: Healthcare
  • Report ID: TNR-110-1056
  • Number of Pages: 420
  • Table/Charts : Yes
  • March, 2024
  • Base Year : 2024
  • No. of Companies : 10+
  • No. of Countries : 29
  • Views : 10063
  • Covid Impact Covered: Yes
  • War Impact Covered: Yes
  • Formats : PDF, Excel, PPT

The mobile gamma cameras market is witnessing rapid growth, driven by increased demand for versatile diagnostic tools. These portable imaging devices play a crucial role in nuclear medicine, allowing real-time monitoring of physiological functions. With technological advancements, mobile gamma cameras offer enhanced resolution and compact designs, making them ideal for various medical settings. The rising prevalence of cardiovascular diseases and cancer has amplified the adoption of these devices for precise diagnostics. Additionally, their flexibility and on-the-go imaging capabilities align with the growing trend of point-of-care diagnostics, contributing to the expanding market for mobile gamma cameras in the healthcare sector. In terms of revenue, the global mobile gamma cameras market was worth US$ 61.9 Mn in 2023 and is anticipated to witness a CAGR of 5.34% during 2024 – 2034

Trends in the Global Mobile Gamma Cameras Market

  • A notable trend in the mobile gamma cameras market is the increasing demand for point-of-care imaging solutions. The portability and flexibility of these devices allow for on-the-spot diagnostics, reducing the need for patients to travel to specialized imaging facilities. This trend aligns with the broader healthcare shift towards decentralized and patient-centric services, emphasizing quick and convenient access to diagnostic tools. The market for mobile gamma cameras is thus evolving to meet the demand for efficient, accessible, and timely imaging solutions in diverse medical settings.
  • The global market for mobile gamma cameras is witnessing a surge in technological innovations, with a focus on enhancing precision and diagnostic capabilities. Advancements such as improved imaging resolution, AI integration, and miniaturization are shaping the industry. These technologies empower healthcare professionals with more accurate and detailed insights, aiding in early disease detection and personalized treatment plans.

Global Mobile Gamma Cameras Market Revenue & Forecast, (US$ Million), 2016 – 2034

Single-head mobile gamma cameras in product type dominated the global market during the forecast period. These devices are cost-effective in both manufacturing and maintenance, making them more affordable for healthcare facilities, especially in resource-constrained environments. Their uncomplicated design and functionality also translate to user-friendly operation, requiring less extensive training for medical professionals. The compact and portable nature of single-head mobile gamma cameras adds to their appeal, enabling versatile deployment across diverse clinical settings. This adaptability addresses the growing demand for on-the-go imaging solutions, contributing to their widespread adoption.

Furthermore, the simplicity of single-head systems doesn’t compromise diagnostic efficiency, making them suitable for routine diagnostics as well as urgent emergencies. In essence, the cost-effectiveness, ease of use, and versatility make single-head mobile gamma cameras the preferred choice, reflecting their dominant market share in the dynamic landscape of mobile gamma camera technologies.

By application segment cardiac imaging segment gained popularity in recent years and is anticipated to grow the fastest over the forecast timeline. With the increasing global burden of cardiovascular diseases, there is a heightened emphasis on early and accurate diagnosis. Mobile gamma cameras, with advancements in resolution and portability, have become instrumental in cardiac imaging, enabling real-time assessment of cardiac function and blood flow. The ability to perform on-the-spot cardiac imaging in diverse clinical settings, including emergencies, has driven the adoption of these devices.

Moreover, the convenience and accessibility offered by mobile gamma cameras align with the growing trend of point-of-care diagnostics, facilitating quicker interventions and personalized treatment plans. As cardiovascular health remains a global health priority, the cardiac imaging segment is anticipated to witness sustained and accelerated growth over the forecast timeline.

Hospitals category accounted for the largest share in 2023 in the global mobile gamma cameras market. Mobile gamma cameras play a pivotal role in comprehensive patient care within hospital settings and have become integral in hospitals for various diagnostic applications, from emergency room evaluations to surgical interventions. The portability of these devices facilitates swift and on-site imaging, contributing to streamlined workflows and immediate decision-making. Hospitals, as central healthcare hubs, prioritize advanced imaging technologies for accurate diagnoses and effective treatment planning.

Moreover, the continuous advancements in mobile gamma camera technology, including enhanced resolution and diagnostic capabilities, make them indispensable tools in a hospital’s diagnostic arsenal. The versatility and adaptability of these devices to diverse medical scenarios reinforce their prominence in hospital settings, substantiating the segment’s significant revenue share in the dynamic landscape of the global mobile gamma cameras market.

Asia Pacific is expected to emerge as the second-leading region in the mobile gamma cameras market, following North America. Rapid economic growth, burgeoning healthcare infrastructure, and increasing investments in medical technologies across countries in the region contribute to heightened adoption. The rising prevalence of chronic diseases has amplified the demand for advanced diagnostic tools, including mobile gamma cameras, fostering market growth.

Moreover, governmental initiatives and healthcare reforms aimed at enhancing medical facilities further drive the uptake of these devices. The evolving healthcare landscape and the need for portable, on-the-go imaging solutions position Asia Pacific as a key player in the global mobile gamma cameras market, second only to North America, reflecting the region’s expanding role in shaping the industry’s trajectory.

Competitive Landscape

In the mobile gamma cameras market, key players engage in fierce competition to secure market share. They prioritize gaining a competitive edge through technological innovations, strategic partnerships, and mergers. The dynamic and evolving nature of the market is evident in companies’ efforts to enhance product portfolios and expand their global presence, showcasing the competitive landscape’s vibrant and challenging dynamics.

Some of the players operating in the mobile gamma cameras market are

  • Beijing Hamamatsu Photon Techniques Inc.
  • CLERAD
  • DDD-Diagnostic A/S
  • DIGIRAD HEALTH, INC.
  • Dilon Technologies, Inc.
  • GAEDE
  • GE Healthcare
  • HTDS
  • Koninklijke Philips N.V.
  • Mediso
  • Medizinsysteme GmbH
  • MIE America
  • Neusoft Medical Systems
  • Siemens Healthcare Private Limited
  • Spectrum Dynamics Medical

Global Mobile Gamma Cameras Market: Key Takeaways 

Report Specifications Details
Market Revenue in 2023 US$ 61.9 Mn
Market Size Forecast by 2034 US$ 117.6 Mn
Growth Rate (CAGR) 5.34%
Historic Data 2016 – 2022
Base Year for Estimation 2023
Forecast Period 2024 – 2034
Report Inclusions Market Size & Estimates, Market Dynamics, Competitive Scenario, Trends, Growth Factors, Market Determinants, Key Investment Segmentation, Product/Service/Solutions Benchmarking
Segments Covered By Product Type, By Application, By End User
Regions Covered North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Countries Covered U.S., Canada, Mexico, Rest of North America,  France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe,  China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific,  Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa,  Brazil, Argentina, Rest of Latin America
Key Players Beijing Hamamatsu Photon Techniques Inc., CLERAD, DDD-Diagnostic A/S, DIGIRAD HEALTH, INC., Dilon Technologies, Inc., GAEDE, GE Healthcare, HTDS, Koninklijke Philips N.V., Mediso, Medizinsysteme GmbH, MIE America, Neusoft Medical Systems, Siemens Healthcare Private Limited, Spectrum Dynamics Medical, Other Market Participants
Customization Scope Customization allows for the inclusion/modification of content pertaining to geographical regions, countries, and specific market segments.
Pricing & Procurement Options Explore purchase options tailored to your specific research requirements
Contact Details Consult With Our Expert

Japan (Toll-Free):  +81 663-386-8111

South Korea (Toll-Free):  +82-808- 703-126

Saudi Arabia (Toll-Free):  +966 800-850-1643

United Kingdom: +44 753-710-5080

United States: +1 302-232-5106

E-mail:  askanexpert@thenicheresearch.com

 

Global Mobile Gamma Cameras Market

By Product Type

  • Single-Head Mobile Gamma Cameras
  • Dual-Head Mobile Gamma Cameras
  • Triple-Head Mobile Gamma Cameras
  • Handheld Mobile Gamma Camera

By Application

  • Brain Imaging
  • Renal Imaging
  • Cardiac Imaging
  • Breast Imaging
  • Hepatobiliary Imaging
  • GI Imaging
  • Bone Scan
  • Thyroid Uptake and Imaging
  • Lymphoscintigraphy
  • Infection Imaging
  • Tagged Red / White Blood Cell Imaging
  • Salivary Imaging
  • Others

By End User

  • Hospitals
  • Imaging Centers & Clinics
  • Research Centers

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)

Report Coverage

Table of Contents

.

1.Market Scope
1.1.Market Segmentation

1.2.Years Considered
1.2.1.Historic Years: 2016 – 2022

1.2.2.Base Year: 2023

1.2.3.Forecast Years: 2024 – 2034

2.Key Target Audiences

3.Research Methodology
3.1.Primary Research
3.1.1.Research Questionnaire

3.1.2.Global Percentage Breakdown

3.1.3.Primary Interviews: Key Opinion Leaders (KOLs)

3.2.Secondary Research
3.2.1.Paid Databases

3.2.2.Secondary Sources

3.3.Market Size Estimates
3.3.1.Top-Down Approach

3.3.2.Bottom-Up Approach

3.4.Data Triangulation Methodology

3.5.Research Assumptions

4.Recommendations and Insights from TNR’s Perspective**

5.Holistic Overview of Mobile Gamma Cameras Market

6.Market Synopsis: Mobile Gamma Cameras Market

7.Mobile Gamma Cameras Market Analysis: Qualitative Perspective
7.1.Introduction
7.1.1.Product Definition

7.1.2.Industry Development

7.2.Market Dynamics
7.2.1.Drivers

7.2.2.Restraints

7.2.3.Opportunities

7.2.4.Challenges

7.3.Trends in Mobile Gamma Cameras Market

7.4.Market Determinants Radar Chart

7.5.Macro-Economic and Micro-Economic Indicators: Mobile Gamma Cameras Market

7.6.Porter’s Five Force Analysis

7.7.Impact of Covid-19 on Mobile Gamma Cameras Market

7.8.PESTEL Analysis

7.9.Value Chain Analysis

7.10.Pricing Analysis, By Region (2023)
7.10.1.North America

7.10.2.Europe

7.10.3.Asia Pacific

7.10.4.Middle East and Africa

7.10.5.Latin America

8.Global Mobile Gamma Cameras Market Analysis and Forecasts, 2024 – 2034
8.1.Overview
8.1.1.Global Mobile Gamma Cameras Market Revenue (US$ Mn)

8.2.Global Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
8.2.1.Single-Head Mobile Gamma Cameras
8.2.1.1.Definition

8.2.1.2.Market Estimation and Penetration, 2016 – 2022

8.2.1.3.Market Forecast, 2024 – 2034

8.2.1.4.Compound Annual Growth Rate (CAGR)

8.2.1.5.Regional Bifurcation
8.2.1.5.1.North America
8.2.1.5.1.1.Market Estimation, 2016 – 2022

8.2.1.5.1.2.Market Forecast, 2024 – 2034

8.2.1.5.2.Europe
8.2.1.5.2.1.Market Estimation, 2016 – 2022

8.2.1.5.2.2.Market Forecast, 2024 – 2034

8.2.1.5.3.Asia Pacific
8.2.1.5.3.1.Market Estimation, 2016 – 2022

8.2.1.5.3.2.Market Forecast, 2024 – 2034

8.2.1.5.4.Middle East and Africa
8.2.1.5.4.1.Market Estimation, 2016 – 2022

8.2.1.5.4.2.Market Forecast, 2024 – 2034

8.2.1.5.5.Latin America
8.2.1.5.5.1.Market Estimation, 2016 – 2022

8.2.1.5.5.2.Market Forecast, 2024 – 2034

8.2.2.Dual-Head Mobile Gamma Cameras
8.2.2.1.Definition

8.2.2.2.Market Estimation and Penetration, 2016 – 2022

8.2.2.3.Market Forecast, 2024 – 2034

8.2.2.4.Compound Annual Growth Rate (CAGR)

8.2.2.5.Regional Bifurcation
8.2.2.5.1.North America
8.2.2.5.1.1.Market Estimation, 2016 – 2022

8.2.2.5.1.2.Market Forecast, 2024 – 2034

8.2.2.5.2.Europe
8.2.2.5.2.1.Market Estimation, 2016 – 2022

8.2.2.5.2.2.Market Forecast, 2024 – 2034

8.2.2.5.3.Asia Pacific
8.2.2.5.3.1.Market Estimation, 2016 – 2022

8.2.2.5.3.2.Market Forecast, 2024 – 2034

8.2.2.5.4.Middle East and Africa
8.2.2.5.4.1.Market Estimation, 2016 – 2022

8.2.2.5.4.2.Market Forecast, 2024 – 2034

8.2.2.5.5.Latin America
8.2.2.5.5.1.Market Estimation, 2016 – 2022

8.2.2.5.5.2.Market Forecast, 2024 – 2034

8.2.3.Triple-Head Mobile Gamma Cameras
8.2.3.1.Definition

8.2.3.2.Market Estimation and Penetration, 2016 – 2022

8.2.3.3.Market Forecast, 2024 – 2034

8.2.3.4.Compound Annual Growth Rate (CAGR)

8.2.3.5.Regional Bifurcation
8.2.3.5.1.North America
8.2.3.5.1.1.Market Estimation, 2016 – 2022

8.2.3.5.1.2.Market Forecast, 2024 – 2034

8.2.3.5.2.Europe
8.2.3.5.2.1.Market Estimation, 2016 – 2022

8.2.3.5.2.2.Market Forecast, 2024 – 2034

8.2.3.5.3.Asia Pacific
8.2.3.5.3.1.Market Estimation, 2016 – 2022

8.2.3.5.3.2.Market Forecast, 2024 – 2034

8.2.3.5.4.Middle East and Africa
8.2.3.5.4.1.Market Estimation, 2016 – 2022

8.2.3.5.4.2.Market Forecast, 2024 – 2034

8.2.3.5.5.Latin America
8.2.3.5.5.1.Market Estimation, 2016 – 2022

8.2.3.5.5.2.Market Forecast, 2024 – 2034

8.2.4.Handheld Mobile Gamma Camera
8.2.4.1.Definition

8.2.4.2.Market Estimation and Penetration, 2016 – 2022

8.2.4.3.Market Forecast, 2024 – 2034

8.2.4.4.Compound Annual Growth Rate (CAGR)

8.2.4.5.Regional Bifurcation
8.2.4.5.1.North America
8.2.4.5.1.1.Market Estimation, 2016 – 2022

8.2.4.5.1.2.Market Forecast, 2024 – 2034

8.2.4.5.2.Europe
8.2.4.5.2.1.Market Estimation, 2016 – 2022

8.2.4.5.2.2.Market Forecast, 2024 – 2034

8.2.4.5.3.Asia Pacific
8.2.4.5.3.1.Market Estimation, 2016 – 2022

8.2.4.5.3.2.Market Forecast, 2024 – 2034

8.2.4.5.4.Middle East and Africa
8.2.4.5.4.1.Market Estimation, 2016 – 2022

8.2.4.5.4.2.Market Forecast, 2024 – 2034

8.2.4.5.5.Latin America
8.2.4.5.5.1.Market Estimation, 2016 – 2022

8.2.4.5.5.2.Market Forecast, 2024 – 2034

8.3.Key Segment for Channeling Investments
8.3.1.By Product Type

9.Global Mobile Gamma Cameras Market Analysis and Forecasts, 2024 – 2034
9.1.Overview

9.2.Global Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
9.2.1.Brain Imaging
9.2.1.1.Definition

9.2.1.2.Market Estimation and Penetration, 2016 – 2022

9.2.1.3.Market Forecast, 2024 – 2034

9.2.1.4.Compound Annual Growth Rate (CAGR)

9.2.1.5.Regional Bifurcation
9.2.1.5.1.North America
9.2.1.5.1.1.Market Estimation, 2016 – 2022

9.2.1.5.1.2.Market Forecast, 2024 – 2034

9.2.1.5.2.Europe
9.2.1.5.2.1.Market Estimation, 2016 – 2022

9.2.1.5.2.2.Market Forecast, 2024 – 2034

9.2.1.5.3.Asia Pacific
9.2.1.5.3.1.Market Estimation, 2016 – 2022

9.2.1.5.3.2.Market Forecast, 2024 – 2034

9.2.1.5.4.Middle East and Africa
9.2.1.5.4.1.Market Estimation, 2016 – 2022

9.2.1.5.4.2.Market Forecast, 2024 – 2034

9.2.1.5.5.Latin America
9.2.1.5.5.1.Market Estimation, 2016 – 2022

9.2.1.5.5.2.Market Forecast, 2024 – 2034

9.2.2.Renal Imaging
9.2.2.1.Definition

9.2.2.2.Market Estimation and Penetration, 2016 – 2022

9.2.2.3.Market Forecast, 2024 – 2034

9.2.2.4.Compound Annual Growth Rate (CAGR)

9.2.2.5.Regional Bifurcation
9.2.2.5.1.North America
9.2.2.5.1.1.Market Estimation, 2016 – 2022

9.2.2.5.1.2.Market Forecast, 2024 – 2034

9.2.2.5.2.Europe
9.2.2.5.2.1.Market Estimation, 2016 – 2022

9.2.2.5.2.2.Market Forecast, 2024 – 2034

9.2.2.5.3.Asia Pacific
9.2.2.5.3.1.Market Estimation, 2016 – 2022

9.2.2.5.3.2.Market Forecast, 2024 – 2034

9.2.2.5.4.Middle East and Africa
9.2.2.5.4.1.Market Estimation, 2016 – 2022

9.2.2.5.4.2.Market Forecast, 2024 – 2034

9.2.2.5.5.Latin America
9.2.2.5.5.1.Market Estimation, 2016 – 2022

9.2.2.5.5.2.Market Forecast, 2024 – 2034

9.2.3.Cardiac Imaging
9.2.3.1.Definition

9.2.3.2.Market Estimation and Penetration, 2016 – 2022

9.2.3.3.Market Forecast, 2024 – 2034

9.2.3.4.Compound Annual Growth Rate (CAGR)

9.2.3.5.Regional Bifurcation
9.2.3.5.1.North America
9.2.3.5.1.1.Market Estimation, 2016 – 2022

9.2.3.5.1.2.Market Forecast, 2024 – 2034

9.2.3.5.2.Europe
9.2.3.5.2.1.Market Estimation, 2016 – 2022

9.2.3.5.2.2.Market Forecast, 2024 – 2034

9.2.3.5.3.Asia Pacific
9.2.3.5.3.1.Market Estimation, 2016 – 2022

9.2.3.5.3.2.Market Forecast, 2024 – 2034

9.2.3.5.4.Middle East and Africa
9.2.3.5.4.1.Market Estimation, 2016 – 2022

9.2.3.5.4.2.Market Forecast, 2024 – 2034

9.2.3.5.5.Latin America
9.2.3.5.5.1.Market Estimation, 2016 – 2022

9.2.3.5.5.2.Market Forecast, 2024 – 2034

9.2.4.Breast Imaging
9.2.4.1.Definition

9.2.4.2.Market Estimation and Penetration, 2016 – 2022

9.2.4.3.Market Forecast, 2024 – 2034

9.2.4.4.Compound Annual Growth Rate (CAGR)

9.2.4.5.Regional Bifurcation
9.2.4.5.1.North America
9.2.4.5.1.1.Market Estimation, 2016 – 2022

9.2.4.5.1.2.Market Forecast, 2024 – 2034

9.2.4.5.2.Europe
9.2.4.5.2.1.Market Estimation, 2016 – 2022

9.2.4.5.2.2.Market Forecast, 2024 – 2034

9.2.4.5.3.Asia Pacific
9.2.4.5.3.1.Market Estimation, 2016 – 2022

9.2.4.5.3.2.Market Forecast, 2024 – 2034

9.2.4.5.4.Middle East and Africa
9.2.4.5.4.1.Market Estimation, 2016 – 2022

9.2.4.5.4.2.Market Forecast, 2024 – 2034

9.2.4.5.5.Latin America
9.2.4.5.5.1.Market Estimation, 2016 – 2022

9.2.4.5.5.2.Market Forecast, 2024 – 2034

9.2.5.Hepatobiliary Imaging
9.2.5.1.Definition

9.2.5.2.Market Estimation and Penetration, 2016 – 2022

9.2.5.3.Market Forecast, 2024 – 2034

9.2.5.4.Compound Annual Growth Rate (CAGR)

9.2.5.5.Regional Bifurcation
9.2.5.5.1.North America
9.2.5.5.1.1.Market Estimation, 2016 – 2022

9.2.5.5.1.2.Market Forecast, 2024 – 2034

9.2.5.5.2.Europe
9.2.5.5.2.1.Market Estimation, 2016 – 2022

9.2.5.5.2.2.Market Forecast, 2024 – 2034

9.2.5.5.3.Asia Pacific
9.2.5.5.3.1.Market Estimation, 2016 – 2022

9.2.5.5.3.2.Market Forecast, 2024 – 2034

9.2.5.5.4.Middle East and Africa
9.2.5.5.4.1.Market Estimation, 2016 – 2022

9.2.5.5.4.2.Market Forecast, 2024 – 2034

9.2.5.5.5.Latin America
9.2.5.5.5.1.Market Estimation, 2016 – 2022

9.2.5.5.5.2.Market Forecast, 2024 – 2034

9.2.6.GI Imaging
9.2.6.1.Definition

9.2.6.2.Market Estimation and Penetration, 2016 – 2022

9.2.6.3.Market Forecast, 2024 – 2034

9.2.6.4.Compound Annual Growth Rate (CAGR)

9.2.6.5.Regional Bifurcation
9.2.6.5.1.North America
9.2.6.5.1.1.Market Estimation, 2016 – 2022

9.2.6.5.1.2.Market Forecast, 2024 – 2034

9.2.6.5.2.Europe
9.2.6.5.2.1.Market Estimation, 2016 – 2022

9.2.6.5.2.2.Market Forecast, 2024 – 2034

9.2.6.5.3.Asia Pacific
9.2.6.5.3.1.Market Estimation, 2016 – 2022

9.2.6.5.3.2.Market Forecast, 2024 – 2034

9.2.6.5.4.Middle East and Africa
9.2.6.5.4.1.Market Estimation, 2016 – 2022

9.2.6.5.4.2.Market Forecast, 2024 – 2034

9.2.6.5.5.Latin America
9.2.6.5.5.1.Market Estimation, 2016 – 2022

9.2.6.5.5.2.Market Forecast, 2024 – 2034

9.2.7.Bone Scan
9.2.7.1.Definition

9.2.7.2.Market Estimation and Penetration, 2016 – 2022

9.2.7.3.Market Forecast, 2024 – 2034

9.2.7.4.Compound Annual Growth Rate (CAGR)

9.2.7.5.Regional Bifurcation
9.2.7.5.1.North America
9.2.7.5.1.1.Market Estimation, 2016 – 2022

9.2.7.5.1.2.Market Forecast, 2024 – 2034

9.2.7.5.2.Europe
9.2.7.5.2.1.Market Estimation, 2016 – 2022

9.2.7.5.2.2.Market Forecast, 2024 – 2034

9.2.7.5.3.Asia Pacific
9.2.7.5.3.1.Market Estimation, 2016 – 2022

9.2.7.5.3.2.Market Forecast, 2024 – 2034

9.2.7.5.4.Middle East and Africa
9.2.7.5.4.1.Market Estimation, 2016 – 2022

9.2.7.5.4.2.Market Forecast, 2024 – 2034

9.2.7.5.5.Latin America
9.2.7.5.5.1.Market Estimation, 2016 – 2022

9.2.7.5.5.2.Market Forecast, 2024 – 2034

9.2.8.Thyroid Uptake and Imaging
9.2.8.1.Definition

9.2.8.2.Market Estimation and Penetration, 2016 – 2022

9.2.8.3.Market Forecast, 2024 – 2034

9.2.8.4.Compound Annual Growth Rate (CAGR)

9.2.8.5.Regional Bifurcation
9.2.8.5.1.North America
9.2.8.5.1.1.Market Estimation, 2016 – 2022

9.2.8.5.1.2.Market Forecast, 2024 – 2034

9.2.8.5.2.Europe
9.2.8.5.2.1.Market Estimation, 2016 – 2022

9.2.8.5.2.2.Market Forecast, 2024 – 2034

9.2.8.5.3.Asia Pacific
9.2.8.5.3.1.Market Estimation, 2016 – 2022

9.2.8.5.3.2.Market Forecast, 2024 – 2034

9.2.8.5.4.Middle East and Africa
9.2.8.5.4.1.Market Estimation, 2016 – 2022

9.2.8.5.4.2.Market Forecast, 2024 – 2034

9.2.8.5.5.Latin America
9.2.8.5.5.1.Market Estimation, 2016 – 2022

9.2.8.5.5.2.Market Forecast, 2024 – 2034

9.2.9.Lymphoscintigraphy 
9.2.9.1.Definition

9.2.9.2.Market Estimation and Penetration, 2016 – 2022

9.2.9.3.Market Forecast, 2024 – 2034

9.2.9.4.Compound Annual Growth Rate (CAGR)

9.2.9.5.Regional Bifurcation
9.2.9.5.1.North America
9.2.9.5.1.1.Market Estimation, 2016 – 2022

9.2.9.5.1.2.Market Forecast, 2024 – 2034

9.2.9.5.2.Europe
9.2.9.5.2.1.Market Estimation, 2016 – 2022

9.2.9.5.2.2.Market Forecast, 2024 – 2034

9.2.9.5.3.Asia Pacific
9.2.9.5.3.1.Market Estimation, 2016 – 2022

9.2.9.5.3.2.Market Forecast, 2024 – 2034

9.2.9.5.4.Middle East and Africa
9.2.9.5.4.1.Market Estimation, 2016 – 2022

9.2.9.5.4.2.Market Forecast, 2024 – 2034

9.2.9.5.5.Latin America
9.2.9.5.5.1.Market Estimation, 2016 – 2022

9.2.9.5.5.2.Market Forecast, 2024 – 2034

9.2.10.Infection Imaging
9.2.10.1.Definition

9.2.10.2.Market Estimation and Penetration, 2016 – 2022

9.2.10.3.Market Forecast, 2024 – 2034

9.2.10.4.Compound Annual Growth Rate (CAGR)

9.2.10.5.Regional Bifurcation
9.2.10.5.1.North America
9.2.10.5.1.1.Market Estimation, 2016 – 2022

9.2.10.5.1.2.Market Forecast, 2024 – 2034

9.2.10.5.2.Europe
9.2.10.5.2.1.Market Estimation, 2016 – 2022

9.2.10.5.2.2.Market Forecast, 2024 – 2034

9.2.10.5.3.Asia Pacific
9.2.10.5.3.1.Market Estimation, 2016 – 2022

9.2.10.5.3.2.Market Forecast, 2024 – 2034

9.2.10.5.4.Middle East and Africa
9.2.10.5.4.1.Market Estimation, 2016 – 2022

9.2.10.5.4.2.Market Forecast, 2024 – 2034

9.2.10.5.5.Latin America
9.2.10.5.5.1.Market Estimation, 2016 – 2022

9.2.10.5.5.2.Market Forecast, 2024 – 2034

9.2.11.Tagged Red or White Blood Cell Imaging
9.2.11.1.Definition

9.2.11.2.Market Estimation and Penetration, 2016 – 2022

9.2.11.3.Market Forecast, 2024 – 2034

9.2.11.4.Compound Annual Growth Rate (CAGR)

9.2.11.5.Regional Bifurcation
9.2.11.5.1.North America
9.2.11.5.1.1.Market Estimation, 2016 – 2022

9.2.11.5.1.2.Market Forecast, 2024 – 2034

9.2.11.5.2.Europe
9.2.11.5.2.1.Market Estimation, 2016 – 2022

9.2.11.5.2.2.Market Forecast, 2024 – 2034

9.2.11.5.3.Asia Pacific
9.2.11.5.3.1.Market Estimation, 2016 – 2022

9.2.11.5.3.2.Market Forecast, 2024 – 2034

9.2.11.5.4.Middle East and Africa
9.2.11.5.4.1.Market Estimation, 2016 – 2022

9.2.11.5.4.2.Market Forecast, 2024 – 2034

9.2.11.5.5.Latin America
9.2.11.5.5.1.Market Estimation, 2016 – 2022

9.2.11.5.5.2.Market Forecast, 2024 – 2034

9.2.12.Salivary Imaging
9.2.12.1.Definition

9.2.12.2.Market Estimation and Penetration, 2016 – 2022

9.2.12.3.Market Forecast, 2024 – 2034

9.2.12.4.Compound Annual Growth Rate (CAGR)

9.2.12.5.Regional Bifurcation
9.2.12.5.1.North America
9.2.12.5.1.1.Market Estimation, 2016 – 2022

9.2.12.5.1.2.Market Forecast, 2024 – 2034

9.2.12.5.2.Europe
9.2.12.5.2.1.Market Estimation, 2016 – 2022

9.2.12.5.2.2.Market Forecast, 2024 – 2034

9.2.12.5.3.Asia Pacific
9.2.12.5.3.1.Market Estimation, 2016 – 2022

9.2.12.5.3.2.Market Forecast, 2024 – 2034

9.2.12.5.4.Middle East and Africa
9.2.12.5.4.1.Market Estimation, 2016 – 2022

9.2.12.5.4.2.Market Forecast, 2024 – 2034

9.2.12.5.5.Latin America
9.2.12.5.5.1.Market Estimation, 2016 – 2022

9.2.12.5.5.2.Market Forecast, 2024 – 2034

9.2.13.Others
9.2.13.1.Definition

9.2.13.2.Market Estimation and Penetration, 2016 – 2022

9.2.13.3.Market Forecast, 2024 – 2034

9.2.13.4.Compound Annual Growth Rate (CAGR)

9.2.13.5.Regional Bifurcation
9.2.13.5.1.North America
9.2.13.5.1.1.Market Estimation, 2016 – 2022

9.2.13.5.1.2.Market Forecast, 2024 – 2034

9.2.13.5.2.Europe
9.2.13.5.2.1.Market Estimation, 2016 – 2022

9.2.13.5.2.2.Market Forecast, 2024 – 2034

9.2.13.5.3.Asia Pacific
9.2.13.5.3.1.Market Estimation, 2016 – 2022

9.2.13.5.3.2.Market Forecast, 2024 – 2034

9.2.13.5.4.Middle East and Africa
9.2.13.5.4.1.Market Estimation, 2016 – 2022

9.2.13.5.4.2.Market Forecast, 2024 – 2034

9.2.13.5.5.Latin America
9.2.13.5.5.1.Market Estimation, 2016 – 2022

9.2.13.5.5.2.Market Forecast, 2024 – 2034

9.3.Key Segment for Channeling Investments
9.3.1.By Application

10.Global Mobile Gamma Cameras Market Analysis and Forecasts, 2024 – 2034
10.1.Overview

10.2.Global Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
10.2.1.Hospitals
10.2.1.1.Definition

10.2.1.2.Market Estimation and Penetration, 2016 – 2022

10.2.1.3.Market Forecast, 2024 – 2034

10.2.1.4.Compound Annual Growth Rate (CAGR)

10.2.1.5.Regional Bifurcation
10.2.1.5.1.North America
10.2.1.5.1.1.Market Estimation, 2016 – 2022

10.2.1.5.1.2.Market Forecast, 2024 – 2034

10.2.1.5.2.Europe
10.2.1.5.2.1.Market Estimation, 2016 – 2022

10.2.1.5.2.2.Market Forecast, 2024 – 2034

10.2.1.5.3.Asia Pacific
10.2.1.5.3.1.Market Estimation, 2016 – 2022

10.2.1.5.3.2.Market Forecast, 2024 – 2034

10.2.1.5.4.Middle East and Africa
10.2.1.5.4.1.Market Estimation, 2016 – 2022

10.2.1.5.4.2.Market Forecast, 2024 – 2034

10.2.1.5.5.Latin America
10.2.1.5.5.1.Market Estimation, 2016 – 2022

10.2.1.5.5.2.Market Forecast, 2024 – 2034

10.2.2.Imaging Centers and Clinics
10.2.2.1.Definition

10.2.2.2.Market Estimation and Penetration, 2016 – 2022

10.2.2.3.Market Forecast, 2024 – 2034

10.2.2.4.Compound Annual Growth Rate (CAGR)

10.2.2.5.Regional Bifurcation
10.2.2.5.1.North America
10.2.2.5.1.1.Market Estimation, 2016 – 2022

10.2.2.5.1.2.Market Forecast, 2024 – 2034

10.2.2.5.2.Europe
10.2.2.5.2.1.Market Estimation, 2016 – 2022

10.2.2.5.2.2.Market Forecast, 2024 – 2034

10.2.2.5.3.Asia Pacific
10.2.2.5.3.1.Market Estimation, 2016 – 2022

10.2.2.5.3.2.Market Forecast, 2024 – 2034

10.2.2.5.4.Middle East and Africa
10.2.2.5.4.1.Market Estimation, 2016 – 2022

10.2.2.5.4.2.Market Forecast, 2024 – 2034

10.2.2.5.5.Latin America
10.2.2.5.5.1.Market Estimation, 2016 – 2022

10.2.2.5.5.2.Market Forecast, 2024 – 2034

10.2.3.Research Centers
10.2.3.1.Definition

10.2.3.2.Market Estimation and Penetration, 2016 – 2022

10.2.3.3.Market Forecast, 2024 – 2034

10.2.3.4.Compound Annual Growth Rate (CAGR)

10.2.3.5.Regional Bifurcation
10.2.3.5.1.North America
10.2.3.5.1.1.Market Estimation, 2016 – 2022

10.2.3.5.1.2.Market Forecast, 2024 – 2034

10.2.3.5.2.Europe
10.2.3.5.2.1.Market Estimation, 2016 – 2022

10.2.3.5.2.2.Market Forecast, 2024 – 2034

10.2.3.5.3.Asia Pacific
10.2.3.5.3.1.Market Estimation, 2016 – 2022

10.2.3.5.3.2.Market Forecast, 2024 – 2034

10.2.3.5.4.Middle East and Africa
10.2.3.5.4.1.Market Estimation, 2016 – 2022

10.2.3.5.4.2.Market Forecast, 2024 – 2034

10.2.3.5.5.Latin America
10.2.3.5.5.1.Market Estimation, 2016 – 2022

10.2.3.5.5.2.Market Forecast, 2024 – 2034

10.3.Key Segment for Channeling Investments
10.3.1.By End User

11.North America Mobile Gamma Cameras Market Analysis and Forecasts, 2024 – 2034
11.1.Overview
11.1.1.North America Mobile Gamma Cameras Market Revenue (US$ Mn)

11.2.North America Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
11.2.1.Single-Head Mobile Gamma Cameras

11.2.2.Dual-Head Mobile Gamma Cameras

11.2.3.Triple-Head Mobile Gamma Cameras

11.2.4.Handheld Mobile Gamma Camera

11.3.North America Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
11.3.1.Brain Imaging

11.3.2.Renal Imaging

11.3.3.Cardiac Imaging

11.3.4.Breast Imaging

11.3.5.Hepatobiliary Imaging

11.3.6.GI Imaging

11.3.7.Bone Scan

11.3.8.Thyroid Uptake and Imaging

11.3.9.Lymphoscintigraphy 

11.3.10.Infection Imaging

11.3.11.Tagged Red or White Blood Cell Imaging

11.3.12.Salivary Imaging

11.3.13.Others

11.4.North America Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
11.4.1.Hospitals

11.4.2.Imaging Centers and Clinics

11.4.3.Research Centers

11.5.North America Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Country
11.5.1.U.S
11.5.1.1.U.S Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
11.5.1.1.1.Single-Head Mobile Gamma Cameras

11.5.1.1.2.Dual-Head Mobile Gamma Cameras

11.5.1.1.3.Triple-Head Mobile Gamma Cameras

11.5.1.1.4.Handheld Mobile Gamma Camera

11.5.1.2.U.S Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
11.5.1.2.1.Brain Imaging

11.5.1.2.2.Renal Imaging

11.5.1.2.3.Cardiac Imaging

11.5.1.2.4.Breast Imaging

11.5.1.2.5.Hepatobiliary Imaging

11.5.1.2.6.GI Imaging

11.5.1.2.7.Bone Scan

11.5.1.2.8.Thyroid Uptake and Imaging

11.5.1.2.9.Lymphoscintigraphy 

11.5.1.2.10.Infection Imaging

11.5.1.2.11.Tagged Red or White Blood Cell Imaging

11.5.1.2.12.Salivary Imaging

11.5.1.2.13.Others

11.5.1.3.U.S Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
11.5.1.3.1.Hospitals

11.5.1.3.2.Imaging Centers and Clinics

11.5.1.3.3.Research Centers

11.5.2.Canada
11.5.2.1.Canada Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
11.5.2.1.1.Single-Head Mobile Gamma Cameras

11.5.2.1.2.Dual-Head Mobile Gamma Cameras

11.5.2.1.3.Triple-Head Mobile Gamma Cameras

11.5.2.1.4.Handheld Mobile Gamma Camera

11.5.2.2.Canada Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
11.5.2.2.1.Brain Imaging

11.5.2.2.2.Renal Imaging

11.5.2.2.3.Cardiac Imaging

11.5.2.2.4.Breast Imaging

11.5.2.2.5.Hepatobiliary Imaging

11.5.2.2.6.GI Imaging

11.5.2.2.7.Bone Scan

11.5.2.2.8.Thyroid Uptake and Imaging

11.5.2.2.9.Lymphoscintigraphy 

11.5.2.2.10.Infection Imaging

11.5.2.2.11.Tagged Red or White Blood Cell Imaging

11.5.2.2.12.Salivary Imaging

11.5.2.2.13.Others

11.5.2.3.Canada Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
11.5.2.3.1.Hospitals

11.5.2.3.2.Imaging Centers and Clinics

11.5.2.3.3.Research Centers

11.5.3.Mexico
11.5.3.1.Mexico Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
11.5.3.1.1.Single-Head Mobile Gamma Cameras

11.5.3.1.2.Dual-Head Mobile Gamma Cameras

11.5.3.1.3.Triple-Head Mobile Gamma Cameras

11.5.3.1.4.Handheld Mobile Gamma Camera

11.5.3.2.Mexico Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
11.5.3.2.1.Brain Imaging

11.5.3.2.2.Renal Imaging

11.5.3.2.3.Cardiac Imaging

11.5.3.2.4.Breast Imaging

11.5.3.2.5.Hepatobiliary Imaging

11.5.3.2.6.GI Imaging

11.5.3.2.7.Bone Scan

11.5.3.2.8.Thyroid Uptake and Imaging

11.5.3.2.9.Lymphoscintigraphy 

11.5.3.2.10.Infection Imaging

11.5.3.2.11.Tagged Red or White Blood Cell Imaging

11.5.3.2.12.Salivary Imaging

11.5.3.2.13.Others

11.5.3.3.Mexico Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
11.5.3.3.1.Hospitals

11.5.3.3.2.Imaging Centers and Clinics

11.5.3.3.3.Research Centers

11.5.4.Rest of North America
11.5.4.1.Rest of North America Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
11.5.4.1.1.Single-Head Mobile Gamma Cameras

11.5.4.1.2.Dual-Head Mobile Gamma Cameras

11.5.4.1.3.Triple-Head Mobile Gamma Cameras

11.5.4.1.4.Handheld Mobile Gamma Camera

11.5.4.2.Rest of North America Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
11.5.4.2.1.Brain Imaging

11.5.4.2.2.Renal Imaging

11.5.4.2.3.Cardiac Imaging

11.5.4.2.4.Breast Imaging

11.5.4.2.5.Hepatobiliary Imaging

11.5.4.2.6.GI Imaging

11.5.4.2.7.Bone Scan

11.5.4.2.8.Thyroid Uptake and Imaging

11.5.4.2.9.Lymphoscintigraphy 

11.5.4.2.10.Infection Imaging

11.5.4.2.11.Tagged Red or White Blood Cell Imaging

11.5.4.2.12.Salivary Imaging

11.5.4.2.13.Others

11.5.4.3.Rest of North America Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
11.5.4.3.1.Hospitals

11.5.4.3.2.Imaging Centers and Clinics

11.5.4.3.3.Research Centers

11.6.Key Segment for Channeling Investments
11.6.1.By Country

11.6.2.By Product Type

11.6.3.By Application

11.6.4.By End User

12.Europe Mobile Gamma Cameras Market Analysis and Forecasts, 2024 – 2034
12.1.Overview
12.1.1.Europe Mobile Gamma Cameras Market Revenue (US$ Mn)

12.2.Europe Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
12.2.1.Single-Head Mobile Gamma Cameras

12.2.2.Dual-Head Mobile Gamma Cameras

12.2.3.Triple-Head Mobile Gamma Cameras

12.2.4.Handheld Mobile Gamma Camera

12.3.Europe Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
12.3.1.Brain Imaging

12.3.2.Renal Imaging

12.3.3.Cardiac Imaging

12.3.4.Breast Imaging

12.3.5.Hepatobiliary Imaging

12.3.6.GI Imaging

12.3.7.Bone Scan

12.3.8.Thyroid Uptake and Imaging

12.3.9.Lymphoscintigraphy 

12.3.10.Infection Imaging

12.3.11.Tagged Red or White Blood Cell Imaging

12.3.12.Salivary Imaging

12.3.13.Others

12.4.Europe Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
12.4.1.Hospitals

12.4.2.Imaging Centers and Clinics

12.4.3.Research Centers

12.5.Europe Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Country
12.5.1.France
12.5.1.1.France Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.1.1.1.Single-Head Mobile Gamma Cameras

12.5.1.1.2.Dual-Head Mobile Gamma Cameras

12.5.1.1.3.Triple-Head Mobile Gamma Cameras

12.5.1.1.4.Handheld Mobile Gamma Camera

12.5.1.2.France Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
12.5.1.2.1.Brain Imaging

12.5.1.2.2.Renal Imaging

12.5.1.2.3.Cardiac Imaging

12.5.1.2.4.Breast Imaging

12.5.1.2.5.Hepatobiliary Imaging

12.5.1.2.6.GI Imaging

12.5.1.2.7.Bone Scan

12.5.1.2.8.Thyroid Uptake and Imaging

12.5.1.2.9.Lymphoscintigraphy 

12.5.1.2.10.Infection Imaging

12.5.1.2.11.Tagged Red or White Blood Cell Imaging

12.5.1.2.12.Salivary Imaging

12.5.1.2.13.Others

12.5.1.3.France Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
12.5.1.3.1.Hospitals

12.5.1.3.2.Imaging Centers and Clinics

12.5.1.3.3.Research Centers

12.5.2.The UK
12.5.2.1.The UK Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.2.1.1.Single-Head Mobile Gamma Cameras

12.5.2.1.2.Dual-Head Mobile Gamma Cameras

12.5.2.1.3.Triple-Head Mobile Gamma Cameras

12.5.2.1.4.Handheld Mobile Gamma Camera

12.5.2.2.The UK Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
12.5.2.2.1.Brain Imaging

12.5.2.2.2.Renal Imaging

12.5.2.2.3.Cardiac Imaging

12.5.2.2.4.Breast Imaging

12.5.2.2.5.Hepatobiliary Imaging

12.5.2.2.6.GI Imaging

12.5.2.2.7.Bone Scan

12.5.2.2.8.Thyroid Uptake and Imaging

12.5.2.2.9.Lymphoscintigraphy 

12.5.2.2.10.Infection Imaging

12.5.2.2.11.Tagged Red or White Blood Cell Imaging

12.5.2.2.12.Salivary Imaging

12.5.2.2.13.Others

12.5.2.3.The UK Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
12.5.2.3.1.Hospitals

12.5.2.3.2.Imaging Centers and Clinics

12.5.2.3.3.Research Centers

12.5.3.Spain
12.5.3.1.Spain Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.3.1.1.Single-Head Mobile Gamma Cameras

12.5.3.1.2.Dual-Head Mobile Gamma Cameras

12.5.3.1.3.Triple-Head Mobile Gamma Cameras

12.5.3.1.4.Handheld Mobile Gamma Camera

12.5.3.2.Spain Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
12.5.3.2.1.Brain Imaging

12.5.3.2.2.Renal Imaging

12.5.3.2.3.Cardiac Imaging

12.5.3.2.4.Breast Imaging

12.5.3.2.5.Hepatobiliary Imaging

12.5.3.2.6.GI Imaging

12.5.3.2.7.Bone Scan

12.5.3.2.8.Thyroid Uptake and Imaging

12.5.3.2.9.Lymphoscintigraphy 

12.5.3.2.10.Infection Imaging

12.5.3.2.11.Tagged Red or White Blood Cell Imaging

12.5.3.2.12.Salivary Imaging

12.5.3.2.13.Others

12.5.3.3.Spain Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
12.5.3.3.1.Hospitals

12.5.3.3.2.Imaging Centers and Clinics

12.5.3.3.3.Research Centers

12.5.4.Germany
12.5.4.1.Germany Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.4.1.1.Single-Head Mobile Gamma Cameras

12.5.4.1.2.Dual-Head Mobile Gamma Cameras

12.5.4.1.3.Triple-Head Mobile Gamma Cameras

12.5.4.1.4.Handheld Mobile Gamma Camera

12.5.4.2.Germany Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
12.5.4.2.1.Brain Imaging

12.5.4.2.2.Renal Imaging

12.5.4.2.3.Cardiac Imaging

12.5.4.2.4.Breast Imaging

12.5.4.2.5.Hepatobiliary Imaging

12.5.4.2.6.GI Imaging

12.5.4.2.7.Bone Scan

12.5.4.2.8.Thyroid Uptake and Imaging

12.5.4.2.9.Lymphoscintigraphy 

12.5.4.2.10.Infection Imaging

12.5.4.2.11.Tagged Red or White Blood Cell Imaging

12.5.4.2.12.Salivary Imaging

12.5.4.2.13.Others

12.5.4.3.Germany Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
12.5.4.3.1.Hospitals

12.5.4.3.2.Imaging Centers and Clinics

12.5.4.3.3.Research Centers

12.5.5.Italy
12.5.5.1.Italy Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.5.1.1.Single-Head Mobile Gamma Cameras

12.5.5.1.2.Dual-Head Mobile Gamma Cameras

12.5.5.1.3.Triple-Head Mobile Gamma Cameras

12.5.5.1.4.Handheld Mobile Gamma Camera

12.5.5.2.Italy Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
12.5.5.2.1.Brain Imaging

12.5.5.2.2.Renal Imaging

12.5.5.2.3.Cardiac Imaging

12.5.5.2.4.Breast Imaging

12.5.5.2.5.Hepatobiliary Imaging

12.5.5.2.6.GI Imaging

12.5.5.2.7.Bone Scan

12.5.5.2.8.Thyroid Uptake and Imaging

12.5.5.2.9.Lymphoscintigraphy 

12.5.5.2.10.Infection Imaging

12.5.5.2.11.Tagged Red or White Blood Cell Imaging

12.5.5.2.12.Salivary Imaging

12.5.5.2.13.Others

12.5.5.3.Italy Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
12.5.5.3.1.Hospitals

12.5.5.3.2.Imaging Centers and Clinics

12.5.5.3.3.Research Centers

12.5.6.Nordic Countries
12.5.6.1.Nordic Countries Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.6.1.1.Single-Head Mobile Gamma Cameras

12.5.6.1.2.Dual-Head Mobile Gamma Cameras

12.5.6.1.3.Triple-Head Mobile Gamma Cameras

12.5.6.1.4.Handheld Mobile Gamma Camera

12.5.6.2.Nordic Countries Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
12.5.6.2.1.Brain Imaging

12.5.6.2.2.Renal Imaging

12.5.6.2.3.Cardiac Imaging

12.5.6.2.4.Breast Imaging

12.5.6.2.5.Hepatobiliary Imaging

12.5.6.2.6.GI Imaging

12.5.6.2.7.Bone Scan

12.5.6.2.8.Thyroid Uptake and Imaging

12.5.6.2.9.Lymphoscintigraphy 

12.5.6.2.10.Infection Imaging

12.5.6.2.11.Tagged Red or White Blood Cell Imaging

12.5.6.2.12.Salivary Imaging

12.5.6.2.13.Others

12.5.6.3.Nordic Countries Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
12.5.6.3.1.Hospitals

12.5.6.3.2.Imaging Centers and Clinics

12.5.6.3.3.Research Centers

12.5.6.4.Nordic Countries Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Country
12.5.6.4.1.Denmark

12.5.6.4.2.Finland

12.5.6.4.3.Iceland

12.5.6.4.4.Sweden

12.5.6.4.5.Norway

12.5.7.Benelux Union
12.5.7.1.Benelux Union Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.7.1.1.Single-Head Mobile Gamma Cameras

12.5.7.1.2.Dual-Head Mobile Gamma Cameras

12.5.7.1.3.Triple-Head Mobile Gamma Cameras

12.5.7.1.4.Handheld Mobile Gamma Camera

12.5.7.2.Benelux Union Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
12.5.7.2.1.Brain Imaging

12.5.7.2.2.Renal Imaging

12.5.7.2.3.Cardiac Imaging

12.5.7.2.4.Breast Imaging

12.5.7.2.5.Hepatobiliary Imaging

12.5.7.2.6.GI Imaging

12.5.7.2.7.Bone Scan

12.5.7.2.8.Thyroid Uptake and Imaging

12.5.7.2.9.Lymphoscintigraphy 

12.5.7.2.10.Infection Imaging

12.5.7.2.11.Tagged Red or White Blood Cell Imaging

12.5.7.2.12.Salivary Imaging

12.5.7.2.13.Others

12.5.7.3.Benelux Union Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
12.5.7.3.1.Hospitals

12.5.7.3.2.Imaging Centers and Clinics

12.5.7.3.3.Research Centers

12.5.7.4.Benelux Union Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1.Belgium

12.5.7.4.2.The Netherlands

12.5.7.4.3.Luxembourg

12.5.8.Rest of Europe
12.5.8.1.Rest of Europe Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.8.1.1.Single-Head Mobile Gamma Cameras

12.5.8.1.2.Dual-Head Mobile Gamma Cameras

12.5.8.1.3.Triple-Head Mobile Gamma Cameras

12.5.8.1.4.Handheld Mobile Gamma Camera

12.5.8.2.Rest of Europe Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
12.5.8.2.1.Brain Imaging

12.5.8.2.2.Renal Imaging

12.5.8.2.3.Cardiac Imaging

12.5.8.2.4.Breast Imaging

12.5.8.2.5.Hepatobiliary Imaging

12.5.8.2.6.GI Imaging

12.5.8.2.7.Bone Scan

12.5.8.2.8.Thyroid Uptake and Imaging

12.5.8.2.9.Lymphoscintigraphy 

12.5.8.2.10.Infection Imaging

12.5.8.2.11.Tagged Red or White Blood Cell Imaging

12.5.8.2.12.Salivary Imaging

12.5.8.2.13.Others

12.5.8.3.Rest of Europe Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
12.5.8.3.1.Hospitals

12.5.8.3.2.Imaging Centers and Clinics

12.5.8.3.3.Research Centers

12.6.Key Segment for Channeling Investments
12.6.1.By Country

12.6.2.By Product Type

12.6.3.By Application

12.6.4.By End User

13.Asia Pacific Mobile Gamma Cameras Market Analysis and Forecasts, 2024 – 2034
13.1.Overview
13.1.1.Asia Pacific Mobile Gamma Cameras Market Revenue (US$ Mn)

13.2.Asia Pacific Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
13.2.1.Single-Head Mobile Gamma Cameras

13.2.2.Dual-Head Mobile Gamma Cameras

13.2.3.Triple-Head Mobile Gamma Cameras

13.2.4.Handheld Mobile Gamma Camera

13.3.Asia Pacific Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
13.3.1.Brain Imaging

13.3.2.Renal Imaging

13.3.3.Cardiac Imaging

13.3.4.Breast Imaging

13.3.5.Hepatobiliary Imaging

13.3.6.GI Imaging

13.3.7.Bone Scan

13.3.8.Thyroid Uptake and Imaging

13.3.9.Lymphoscintigraphy 

13.3.10.Infection Imaging

13.3.11.Tagged Red or White Blood Cell Imaging

13.3.12.Salivary Imaging

13.3.13.Others

13.4.Asia Pacific Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
13.4.1.Hospitals

13.4.2.Imaging Centers and Clinics

13.4.3.Research Centers

13.5.Asia Pacific Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Country
13.5.1.China
13.5.1.1.China Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.1.1.1.Single-Head Mobile Gamma Cameras

13.5.1.1.2.Dual-Head Mobile Gamma Cameras

13.5.1.1.3.Triple-Head Mobile Gamma Cameras

13.5.1.1.4.Handheld Mobile Gamma Camera

13.5.1.2.China Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
13.5.1.2.1.Brain Imaging

13.5.1.2.2.Renal Imaging

13.5.1.2.3.Cardiac Imaging

13.5.1.2.4.Breast Imaging

13.5.1.2.5.Hepatobiliary Imaging

13.5.1.2.6.GI Imaging

13.5.1.2.7.Bone Scan

13.5.1.2.8.Thyroid Uptake and Imaging

13.5.1.2.9.Lymphoscintigraphy 

13.5.1.2.10.Infection Imaging

13.5.1.2.11.Tagged Red or White Blood Cell Imaging

13.5.1.2.12.Salivary Imaging

13.5.1.2.13.Others

13.5.1.3.China Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
13.5.1.3.1.Hospitals

13.5.1.3.2.Imaging Centers and Clinics

13.5.1.3.3.Research Centers

13.5.2.Japan
13.5.2.1.Japan Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.2.1.1.Single-Head Mobile Gamma Cameras

13.5.2.1.2.Dual-Head Mobile Gamma Cameras

13.5.2.1.3.Triple-Head Mobile Gamma Cameras

13.5.2.1.4.Handheld Mobile Gamma Camera

13.5.2.2.Japan Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
13.5.2.2.1.Brain Imaging

13.5.2.2.2.Renal Imaging

13.5.2.2.3.Cardiac Imaging

13.5.2.2.4.Breast Imaging

13.5.2.2.5.Hepatobiliary Imaging

13.5.2.2.6.GI Imaging

13.5.2.2.7.Bone Scan

13.5.2.2.8.Thyroid Uptake and Imaging

13.5.2.2.9.Lymphoscintigraphy 

13.5.2.2.10.Infection Imaging

13.5.2.2.11.Tagged Red or White Blood Cell Imaging

13.5.2.2.12.Salivary Imaging

13.5.2.2.13.Others

13.5.2.3.Japan Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
13.5.2.3.1.Hospitals

13.5.2.3.2.Imaging Centers and Clinics

13.5.2.3.3.Research Centers

13.5.3.India
13.5.3.1.India Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.3.1.1.Single-Head Mobile Gamma Cameras

13.5.3.1.2.Dual-Head Mobile Gamma Cameras

13.5.3.1.3.Triple-Head Mobile Gamma Cameras

13.5.3.1.4.Handheld Mobile Gamma Camera

13.5.3.2.India Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
13.5.3.2.1.Brain Imaging

13.5.3.2.2.Renal Imaging

13.5.3.2.3.Cardiac Imaging

13.5.3.2.4.Breast Imaging

13.5.3.2.5.Hepatobiliary Imaging

13.5.3.2.6.GI Imaging

13.5.3.2.7.Bone Scan

13.5.3.2.8.Thyroid Uptake and Imaging

13.5.3.2.9.Lymphoscintigraphy 

13.5.3.2.10.Infection Imaging

13.5.3.2.11.Tagged Red or White Blood Cell Imaging

13.5.3.2.12.Salivary Imaging

13.5.3.2.13.Others

13.5.3.3.India Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
13.5.3.3.1.Hospitals

13.5.3.3.2.Imaging Centers and Clinics

13.5.3.3.3.Research Centers

13.5.4.New Zealand
13.5.4.1.New Zealand Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.4.1.1.Single-Head Mobile Gamma Cameras

13.5.4.1.2.Dual-Head Mobile Gamma Cameras

13.5.4.1.3.Triple-Head Mobile Gamma Cameras

13.5.4.1.4.Handheld Mobile Gamma Camera

13.5.4.2.New Zealand Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
13.5.4.2.1.Brain Imaging

13.5.4.2.2.Renal Imaging

13.5.4.2.3.Cardiac Imaging

13.5.4.2.4.Breast Imaging

13.5.4.2.5.Hepatobiliary Imaging

13.5.4.2.6.GI Imaging

13.5.4.2.7.Bone Scan

13.5.4.2.8.Thyroid Uptake and Imaging

13.5.4.2.9.Lymphoscintigraphy 

13.5.4.2.10.Infection Imaging

13.5.4.2.11.Tagged Red or White Blood Cell Imaging

13.5.4.2.12.Salivary Imaging

13.5.4.2.13.Others

13.5.4.3.New Zealand Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
13.5.4.3.1.Hospitals

13.5.4.3.2.Imaging Centers and Clinics

13.5.4.3.3.Research Centers

13.5.5.Australia
13.5.5.1.Australia Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.5.1.1.Single-Head Mobile Gamma Cameras

13.5.5.1.2.Dual-Head Mobile Gamma Cameras

13.5.5.1.3.Triple-Head Mobile Gamma Cameras

13.5.5.1.4.Handheld Mobile Gamma Camera

13.5.5.2.Australia Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
13.5.5.2.1.Brain Imaging

13.5.5.2.2.Renal Imaging

13.5.5.2.3.Cardiac Imaging

13.5.5.2.4.Breast Imaging

13.5.5.2.5.Hepatobiliary Imaging

13.5.5.2.6.GI Imaging

13.5.5.2.7.Bone Scan

13.5.5.2.8.Thyroid Uptake and Imaging

13.5.5.2.9.Lymphoscintigraphy 

13.5.5.2.10.Infection Imaging

13.5.5.2.11.Tagged Red or White Blood Cell Imaging

13.5.5.2.12.Salivary Imaging

13.5.5.2.13.Others

13.5.5.3.Australia Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
13.5.5.3.1.Hospitals

13.5.5.3.2.Imaging Centers and Clinics

13.5.5.3.3.Research Centers

13.5.6.South Korea
13.5.6.1.South Korea Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.6.1.1.Single-Head Mobile Gamma Cameras

13.5.6.1.2.Dual-Head Mobile Gamma Cameras

13.5.6.1.3.Triple-Head Mobile Gamma Cameras

13.5.6.1.4.Handheld Mobile Gamma Camera

13.5.6.2.South Korea Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
13.5.6.2.1.Brain Imaging

13.5.6.2.2.Renal Imaging

13.5.6.2.3.Cardiac Imaging

13.5.6.2.4.Breast Imaging

13.5.6.2.5.Hepatobiliary Imaging

13.5.6.2.6.GI Imaging

13.5.6.2.7.Bone Scan

13.5.6.2.8.Thyroid Uptake and Imaging

13.5.6.2.9.Lymphoscintigraphy 

13.5.6.2.10.Infection Imaging

13.5.6.2.11.Tagged Red or White Blood Cell Imaging

13.5.6.2.12.Salivary Imaging

13.5.6.2.13.Others

13.5.6.3.South Korea Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
13.5.6.3.1.Hospitals

13.5.6.3.2.Imaging Centers and Clinics

13.5.6.3.3.Research Centers

13.5.7.Southeast Asia
13.5.7.1.Southeast Asia Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.7.1.1.Single-Head Mobile Gamma Cameras

13.5.7.1.2.Dual-Head Mobile Gamma Cameras

13.5.7.1.3.Triple-Head Mobile Gamma Cameras

13.5.7.1.4.Handheld Mobile Gamma Camera

13.5.7.2.Southeast Asia Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
13.5.7.2.1.Brain Imaging

13.5.7.2.2.Renal Imaging

13.5.7.2.3.Cardiac Imaging

13.5.7.2.4.Breast Imaging

13.5.7.2.5.Hepatobiliary Imaging

13.5.7.2.6.GI Imaging

13.5.7.2.7.Bone Scan

13.5.7.2.8.Thyroid Uptake and Imaging

13.5.7.2.9.Lymphoscintigraphy 

13.5.7.2.10.Infection Imaging

13.5.7.2.11.Tagged Red or White Blood Cell Imaging

13.5.7.2.12.Salivary Imaging

13.5.7.2.13.Others

13.5.7.3.Southeast Asia Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
13.5.7.3.1.Hospitals

13.5.7.3.2.Imaging Centers and Clinics

13.5.7.3.3.Research Centers

13.5.7.4.Southeast Asia Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1.Indonesia

13.5.7.4.2.Thailand

13.5.7.4.3.Malaysia

13.5.7.4.4.Singapore

13.5.7.4.5.Rest of Southeast Asia

13.5.8.Rest of Asia Pacific
13.5.8.1.Rest of Asia Pacific Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.8.1.1.Single-Head Mobile Gamma Cameras

13.5.8.1.2.Dual-Head Mobile Gamma Cameras

13.5.8.1.3.Triple-Head Mobile Gamma Cameras

13.5.8.1.4.Handheld Mobile Gamma Camera

13.5.8.2.Rest of Asia Pacific Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
13.5.8.2.1.Brain Imaging

13.5.8.2.2.Renal Imaging

13.5.8.2.3.Cardiac Imaging

13.5.8.2.4.Breast Imaging

13.5.8.2.5.Hepatobiliary Imaging

13.5.8.2.6.GI Imaging

13.5.8.2.7.Bone Scan

13.5.8.2.8.Thyroid Uptake and Imaging

13.5.8.2.9.Lymphoscintigraphy 

13.5.8.2.10.Infection Imaging

13.5.8.2.11.Tagged Red or White Blood Cell Imaging

13.5.8.2.12.Salivary Imaging

13.5.8.2.13.Others

13.5.8.3.Rest of Asia Pacific Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
13.5.8.3.1.Hospitals

13.5.8.3.2.Imaging Centers and Clinics

13.5.8.3.3.Research Centers

13.6.Key Segment for Channeling Investments
13.6.1.By Country

13.6.2.By Product Type

13.6.3.By Application

13.6.4.By End User

14.Middle East and Africa Mobile Gamma Cameras Market Analysis and Forecasts, 2024 – 2034
14.1.Overview
14.1.1.Middle East and Africa Mobile Gamma Cameras Market Revenue (US$ Mn)

14.2.Middle East and Africa Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
14.2.1.Single-Head Mobile Gamma Cameras

14.2.2.Dual-Head Mobile Gamma Cameras

14.2.3.Triple-Head Mobile Gamma Cameras

14.2.4.Handheld Mobile Gamma Camera

14.3.Middle East and Africa Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
14.3.1.Brain Imaging

14.3.2.Renal Imaging

14.3.3.Cardiac Imaging

14.3.4.Breast Imaging

14.3.5.Hepatobiliary Imaging

14.3.6.GI Imaging

14.3.7.Bone Scan

14.3.8.Thyroid Uptake and Imaging

14.3.9.Lymphoscintigraphy 

14.3.10.Infection Imaging

14.3.11.Tagged Red or White Blood Cell Imaging

14.3.12.Salivary Imaging

14.3.13.Others

14.4.Middle East and Africa Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
14.4.1.Hospitals

14.4.2.Imaging Centers and Clinics

14.4.3.Research Centers

14.5.Middle East and Africa Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Country
14.5.1.Saudi Arabia
14.5.1.1.Saudi Arabia Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
14.5.1.1.1.Single-Head Mobile Gamma Cameras

14.5.1.1.2.Dual-Head Mobile Gamma Cameras

14.5.1.1.3.Triple-Head Mobile Gamma Cameras

14.5.1.1.4.Handheld Mobile Gamma Camera

14.5.1.2.Saudi Arabia Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
14.5.1.2.1.Brain Imaging

14.5.1.2.2.Renal Imaging

14.5.1.2.3.Cardiac Imaging

14.5.1.2.4.Breast Imaging

14.5.1.2.5.Hepatobiliary Imaging

14.5.1.2.6.GI Imaging

14.5.1.2.7.Bone Scan

14.5.1.2.8.Thyroid Uptake and Imaging

14.5.1.2.9.Lymphoscintigraphy 

14.5.1.2.10.Infection Imaging

14.5.1.2.11.Tagged Red or White Blood Cell Imaging

14.5.1.2.12.Salivary Imaging

14.5.1.2.13.Others

14.5.1.3.Saudi Arabia Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
14.5.1.3.1.Hospitals

14.5.1.3.2.Imaging Centers and Clinics

14.5.1.3.3.Research Centers

14.5.2.UAE
14.5.2.1.UAE Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
14.5.2.1.1.Single-Head Mobile Gamma Cameras

14.5.2.1.2.Dual-Head Mobile Gamma Cameras

14.5.2.1.3.Triple-Head Mobile Gamma Cameras

14.5.2.1.4.Handheld Mobile Gamma Camera

14.5.2.2.UAE Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
14.5.2.2.1.Brain Imaging

14.5.2.2.2.Renal Imaging

14.5.2.2.3.Cardiac Imaging

14.5.2.2.4.Breast Imaging

14.5.2.2.5.Hepatobiliary Imaging

14.5.2.2.6.GI Imaging

14.5.2.2.7.Bone Scan

14.5.2.2.8.Thyroid Uptake and Imaging

14.5.2.2.9.Lymphoscintigraphy 

14.5.2.2.10.Infection Imaging

14.5.2.2.11.Tagged Red or White Blood Cell Imaging

14.5.2.2.12.Salivary Imaging

14.5.2.2.13.Others

14.5.2.3.UAE Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
14.5.2.3.1.Hospitals

14.5.2.3.2.Imaging Centers and Clinics

14.5.2.3.3.Research Centers

14.5.3.Egypt
14.5.3.1.Egypt Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
14.5.3.1.1.Single-Head Mobile Gamma Cameras

14.5.3.1.2.Dual-Head Mobile Gamma Cameras

14.5.3.1.3.Triple-Head Mobile Gamma Cameras

14.5.3.1.4.Handheld Mobile Gamma Camera

14.5.3.2.Egypt Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
14.5.3.2.1.Brain Imaging

14.5.3.2.2.Renal Imaging

14.5.3.2.3.Cardiac Imaging

14.5.3.2.4.Breast Imaging

14.5.3.2.5.Hepatobiliary Imaging

14.5.3.2.6.GI Imaging

14.5.3.2.7.Bone Scan

14.5.3.2.8.Thyroid Uptake and Imaging

14.5.3.2.9.Lymphoscintigraphy 

14.5.3.2.10.Infection Imaging

14.5.3.2.11.Tagged Red or White Blood Cell Imaging

14.5.3.2.12.Salivary Imaging

14.5.3.2.13.Others

14.5.3.3.Egypt Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
14.5.3.3.1.Hospitals

14.5.3.3.2.Imaging Centers and Clinics

14.5.3.3.3.Research Centers

14.5.4.Kuwait
14.5.4.1.Kuwait Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
14.5.4.1.1.Single-Head Mobile Gamma Cameras

14.5.4.1.2.Dual-Head Mobile Gamma Cameras

14.5.4.1.3.Triple-Head Mobile Gamma Cameras

14.5.4.1.4.Handheld Mobile Gamma Camera

14.5.4.2.Kuwait Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
14.5.4.2.1.Brain Imaging

14.5.4.2.2.Renal Imaging

14.5.4.2.3.Cardiac Imaging

14.5.4.2.4.Breast Imaging

14.5.4.2.5.Hepatobiliary Imaging

14.5.4.2.6.GI Imaging

14.5.4.2.7.Bone Scan

14.5.4.2.8.Thyroid Uptake and Imaging

14.5.4.2.9.Lymphoscintigraphy 

14.5.4.2.10.Infection Imaging

14.5.4.2.11.Tagged Red or White Blood Cell Imaging

14.5.4.2.12.Salivary Imaging

14.5.4.2.13.Others

14.5.4.3.Kuwait Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
14.5.4.3.1.Hospitals

14.5.4.3.2.Imaging Centers and Clinics

14.5.4.3.3.Research Centers

14.5.5.South Africa
14.5.5.1.South Africa Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
14.5.5.1.1.Single-Head Mobile Gamma Cameras

14.5.5.1.2.Dual-Head Mobile Gamma Cameras

14.5.5.1.3.Triple-Head Mobile Gamma Cameras

14.5.5.1.4.Handheld Mobile Gamma Camera

14.5.5.2.South Africa Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
14.5.5.2.1.Brain Imaging

14.5.5.2.2.Renal Imaging

14.5.5.2.3.Cardiac Imaging

14.5.5.2.4.Breast Imaging

14.5.5.2.5.Hepatobiliary Imaging

14.5.5.2.6.GI Imaging

14.5.5.2.7.Bone Scan

14.5.5.2.8.Thyroid Uptake and Imaging

14.5.5.2.9.Lymphoscintigraphy 

14.5.5.2.10.Infection Imaging

14.5.5.2.11.Tagged Red or White Blood Cell Imaging

14.5.5.2.12.Salivary Imaging

14.5.5.2.13.Others

14.5.5.3.South Africa Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
14.5.5.3.1.Hospitals

14.5.5.3.2.Imaging Centers and Clinics

14.5.5.3.3.Research Centers

14.5.6.Rest of Middle East & Africa
14.5.6.1.Rest of Middle East & Africa Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
14.5.6.1.1.Single-Head Mobile Gamma Cameras

14.5.6.1.2.Dual-Head Mobile Gamma Cameras

14.5.6.1.3.Triple-Head Mobile Gamma Cameras

14.5.6.1.4.Handheld Mobile Gamma Camera

14.5.6.2.Rest of Middle East & Africa Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
14.5.6.2.1.Brain Imaging

14.5.6.2.2.Renal Imaging

14.5.6.2.3.Cardiac Imaging

14.5.6.2.4.Breast Imaging

14.5.6.2.5.Hepatobiliary Imaging

14.5.6.2.6.GI Imaging

14.5.6.2.7.Bone Scan

14.5.6.2.8.Thyroid Uptake and Imaging

14.5.6.2.9.Lymphoscintigraphy 

14.5.6.2.10.Infection Imaging

14.5.6.2.11.Tagged Red or White Blood Cell Imaging

14.5.6.2.12.Salivary Imaging

14.5.6.2.13.Others

14.5.6.3.Rest of Middle East & Africa Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
14.5.6.3.1.Hospitals

14.5.6.3.2.Imaging Centers and Clinics

14.5.6.3.3.Research Centers

14.6.Key Segment for Channeling Investments
14.6.1.By Country

14.6.2.By Product Type

14.6.3.By Application

14.6.4.By End User

15.Latin America Mobile Gamma Cameras Market Analysis and Forecasts, 2024 – 2034
15.1.Overview
15.1.1.Latin America Mobile Gamma Cameras Market Revenue (US$ Mn)

15.2.Latin America Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
15.2.1.Single-Head Mobile Gamma Cameras

15.2.2.Dual-Head Mobile Gamma Cameras

15.2.3.Triple-Head Mobile Gamma Cameras

15.2.4.Handheld Mobile Gamma Camera

15.3.Latin America Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
15.3.1.Brain Imaging

15.3.2.Renal Imaging

15.3.3.Cardiac Imaging

15.3.4.Breast Imaging

15.3.5.Hepatobiliary Imaging

15.3.6.GI Imaging

15.3.7.Bone Scan

15.3.8.Thyroid Uptake and Imaging

15.3.9.Lymphoscintigraphy 

15.3.10.Infection Imaging

15.3.11.Tagged Red or White Blood Cell Imaging

15.3.12.Salivary Imaging

15.3.13.Others

15.4.Latin America Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
15.4.1.Hospitals

15.4.2.Imaging Centers and Clinics

15.4.3.Research Centers

15.5.Latin America Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Country
15.5.1.Brazil
15.5.1.1.Brazil Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
15.5.1.1.1.Single-Head Mobile Gamma Cameras

15.5.1.1.2.Dual-Head Mobile Gamma Cameras

15.5.1.1.3.Triple-Head Mobile Gamma Cameras

15.5.1.1.4.Handheld Mobile Gamma Camera

15.5.1.2.Brazil Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
15.5.1.2.1.Brain Imaging

15.5.1.2.2.Renal Imaging

15.5.1.2.3.Cardiac Imaging

15.5.1.2.4.Breast Imaging

15.5.1.2.5.Hepatobiliary Imaging

15.5.1.2.6.GI Imaging

15.5.1.2.7.Bone Scan

15.5.1.2.8.Thyroid Uptake and Imaging

15.5.1.2.9.Lymphoscintigraphy 

15.5.1.2.10.Infection Imaging

15.5.1.2.11.Tagged Red or White Blood Cell Imaging

15.5.1.2.12.Salivary Imaging

15.5.1.2.13.Others

15.5.1.3.Brazil Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
15.5.1.3.1.Hospitals

15.5.1.3.2.Imaging Centers and Clinics

15.5.1.3.3.Research Centers

15.5.2.Argentina
15.5.2.1.Argentina Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
15.5.2.1.1.Single-Head Mobile Gamma Cameras

15.5.2.1.2.Dual-Head Mobile Gamma Cameras

15.5.2.1.3.Triple-Head Mobile Gamma Cameras

15.5.2.1.4.Handheld Mobile Gamma Camera

15.5.2.2.Argentina Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
15.5.2.2.1.Brain Imaging

15.5.2.2.2.Renal Imaging

15.5.2.2.3.Cardiac Imaging

15.5.2.2.4.Breast Imaging

15.5.2.2.5.Hepatobiliary Imaging

15.5.2.2.6.GI Imaging

15.5.2.2.7.Bone Scan

15.5.2.2.8.Thyroid Uptake and Imaging

15.5.2.2.9.Lymphoscintigraphy 

15.5.2.2.10.Infection Imaging

15.5.2.2.11.Tagged Red or White Blood Cell Imaging

15.5.2.2.12.Salivary Imaging

15.5.2.2.13.Others

15.5.2.3.Argentina Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
15.5.2.3.1.Hospitals

15.5.2.3.2.Imaging Centers and Clinics

15.5.2.3.3.Research Centers

15.5.3.Rest of Latin America
15.5.3.1.Rest of Latin America Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Product Type
15.5.3.1.1.Single-Head Mobile Gamma Cameras

15.5.3.1.2.Dual-Head Mobile Gamma Cameras

15.5.3.1.3.Triple-Head Mobile Gamma Cameras

15.5.3.1.4.Handheld Mobile Gamma Camera

15.5.3.2.Rest of Latin America Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By Application
15.5.3.2.1.Brain Imaging

15.5.3.2.2.Renal Imaging

15.5.3.2.3.Cardiac Imaging

15.5.3.2.4.Breast Imaging

15.5.3.2.5.Hepatobiliary Imaging

15.5.3.2.6.GI Imaging

15.5.3.2.7.Bone Scan

15.5.3.2.8.Thyroid Uptake and Imaging

15.5.3.2.9.Lymphoscintigraphy 

15.5.3.2.10.Infection Imaging

15.5.3.2.11.Tagged Red or White Blood Cell Imaging

15.5.3.2.12.Salivary Imaging

15.5.3.2.13.Others

15.5.3.3.Rest of Latin America Mobile Gamma Cameras Market Revenue (US$ Mn) and Forecasts, By End User
15.5.3.3.1.Hospitals

15.5.3.3.2.Imaging Centers and Clinics

15.5.3.3.3.Research Centers

15.6.Key Segment for Channeling Investments
15.6.1.By Country

15.6.2.By Product Type

15.6.3.By Application

15.6.4.By End User

16.Competitive Benchmarking
16.1.Brand Benchmarking

16.2.Market Share Analysis, 2020

16.3.Global Presence and Growth Strategies
16.3.1.Mergers and Acquisitions

16.3.2.Product Launches

16.3.3.Investments Trends

16.3.4.R&D Initiatives

17.Player Profiles
17.1.Beijing Hamamatsu Photon Techniques Inc.
17.1.1.Company Details

17.1.2.Company Overview

17.1.3.Product Offerings

17.1.4.Key Developments

17.1.5.Financial Analysis

17.1.6.SWOT Analysis

17.1.7.Business Strategies

17.2.CLERAD
17.2.1.Company Details

17.2.2.Company Overview

17.2.3.Product Offerings

17.2.4.Key Developments

17.2.5.Financial Analysis

17.2.6.SWOT Analysis

17.2.7.Business Strategies

17.3.DDD-Diagnostic A/S
17.3.1.Company Details

17.3.2.Company Overview

17.3.3.Product Offerings

17.3.4.Key Developments

17.3.5.Financial Analysis

17.3.6.SWOT Analysis

17.3.7.Business Strategies

17.4.DIGIRAD HEALTH, INC. 
17.4.1.Company Details

17.4.2.Company Overview

17.4.3.Product Offerings

17.4.4.Key Developments

17.4.5.Financial Analysis

17.4.6.SWOT Analysis

17.4.7.Business Strategies

17.5.Dilon Technologies, Inc.
17.5.1.Company Details

17.5.2.Company Overview

17.5.3.Product Offerings

17.5.4.Key Developments

17.5.5.Financial Analysis

17.5.6.SWOT Analysis

17.5.7.Business Strategies

17.6.GAEDE
17.6.1.Company Details

17.6.2.Company Overview

17.6.3.Product Offerings

17.6.4.Key Developments

17.6.5.Financial Analysis

17.6.6.SWOT Analysis

17.6.7.Business Strategies

17.7.GE Healthcare
17.7.1.Company Details

17.7.2.Company Overview

17.7.3.Product Offerings

17.7.4.Key Developments

17.7.5.Financial Analysis

17.7.6.SWOT Analysis

17.7.7.Business Strategies

17.8.HTDS 
17.8.1.Company Details

17.8.2.Company Overview

17.8.3.Product Offerings

17.8.4.Key Developments

17.8.5.Financial Analysis

17.8.6.SWOT Analysis

17.8.7.Business Strategies

17.9.Koninklijke Philips N.V.
17.9.1.Company Details

17.9.2.Company Overview

17.9.3.Product Offerings

17.9.4.Key Developments

17.9.5.Financial Analysis

17.9.6.SWOT Analysis

17.9.7.Business Strategies

17.10.Mediso
17.10.1.Company Details

17.10.2.Company Overview

17.10.3.Product Offerings

17.10.4.Key Developments

17.10.5.Financial Analysis

17.10.6.SWOT Analysis

17.10.7.Business Strategies

17.11.Medizinsysteme GmbH
17.11.1.Company Details

17.11.2.Company Overview

17.11.3.Product Offerings

17.11.4.Key Developments

17.11.5.Financial Analysis

17.11.6.SWOT Analysis

17.11.7.Business Strategies

17.12.MIE America
17.12.1.Company Details

17.12.2.Company Overview

17.12.3.Product Offerings

17.12.4.Key Developments

17.12.5.Financial Analysis

17.12.6.SWOT Analysis

17.12.7.Business Strategies

17.13.Neusoft Medical Systems
17.13.1.Company Details

17.13.2.Company Overview

17.13.3.Product Offerings

17.13.4.Key Developments

17.13.5.Financial Analysis

17.13.6.SWOT Analysis

17.13.7.Business Strategies

17.14.Siemens Healthcare Private Limited
17.14.1.Company Details

17.14.2.Company Overview

17.14.3.Product Offerings

17.14.4.Key Developments

17.14.5.Financial Analysis

17.14.6.SWOT Analysis

17.14.7.Business Strategies

17.15.Spectrum Dynamics Medical
17.15.1.Company Details

17.15.2.Company Overview

17.15.3.Product Offerings

17.15.4.Key Developments

17.15.5.Financial Analysis

17.15.6.SWOT Analysis

17.15.7.Business Strategies

17.16.Others

18.Key Findings

.

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

.

**Exclusive for Multi-User and Enterprise User.

.

.

.

.

.

.

.

.

.

.

.

.

.

  .

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

  .

Global Mobile Gamma Cameras Market

By Product Type

  • Single-Head Mobile Gamma Cameras
  • Dual-Head Mobile Gamma Cameras
  • Triple-Head Mobile Gamma Cameras
  • Handheld Mobile Gamma Camera

By Application

  • Brain Imaging
  • Renal Imaging
  • Cardiac Imaging
  • Breast Imaging
  • Hepatobiliary Imaging
  • GI Imaging
  • Bone Scan
  • Thyroid Uptake and Imaging
  • Lymphoscintigraphy
  • Infection Imaging
  • Tagged Red / White Blood Cell Imaging
  • Salivary Imaging
  • Others

By End User

  • Hospitals
  • Imaging Centers & Clinics
  • Research Centers

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)

.

The Niche Research approach encompasses both primary and secondary research methods to provide comprehensive insights. While primary research is the cornerstone of our studies, we also incorporate secondary research sources such as company annual reports, premium industry databases, press releases, industry journals, and white papers.

Within our primary research, we actively engage with various industry stakeholders, conducting paid interviews and surveys. Our meticulous analysis extends to every market participant in major countries, allowing us to thoroughly examine their portfolios, calculate market shares, and segment revenues.

Our data collection primarily focuses on individual countries within our research scope, enabling us to estimate regional market sizes. Typically, we employ a bottom-up approach, meticulously tracking trends in different countries. We analyze growth drivers, constraints, technological innovations, and opportunities for each country, ultimately arriving at regional figures.Our process begins by examining the growth prospects of each country. Building upon these insights, we project growth and trends for the entire region. Finally, we utilize our proprietary model to refine estimations and forecasts.

Our data validation standards are integral to ensuring the reliability and accuracy of our research findings. Here’s a breakdown of our data validation processes and the stakeholders we engage with during our primary research:

  • Supply Side Analysis: We initiate a supply side analysis by directly contacting market participants, through telephonic interviews and questionnaires containing both open-ended and close-ended questions. We gather information on their portfolios, segment revenues, developments, and growth strategies.
  • Demand Side Analysis: To gain insights into adoption trends and consumer preferences, we reach out to target customers and users (non-vendors). This information forms a vital part of the qualitative analysis section of our reports, covering market dynamics, adoption trends, consumer behavior, spending patterns, and other related aspects.
  • Consultant Insights: We tap into the expertise of our partner consultants from around the world to obtain their unique viewpoints and perspectives. Their insights contribute to a well-rounded understanding of the markets under investigation.
  • In-House Validation: To ensure data accuracy and reliability, we conduct cross-validation of data points and information through our in-house team of consultants and utilize advanced data modeling tools for thorough verification.

The forecasts we provide are based on a comprehensive assessment of various factors, including:

  • Market Trends and Past Performance (Last Five Years): We accurately analyze market trends and performance data from preceding five years to identify historical patterns and understand the market’s evolution.
  • Historical Performance and Growth of Market Participants: We assess the historical performance and growth trajectories of key market participants. This analysis provides insights into the competitive landscape and individual company strategies.
  • Market Determinants Impact Analysis (Next Eight Years): We conduct a rigorous analysis of the factors that are projected to influence the market over the next eight years. This includes assessing both internal and external determinants that can shape market dynamics.
  • Drivers and Challenges for the Forecast Period:Identify the factors expected to drive market growth during the forecast period, as well as the challenges that the industry may face. This analysis aids in deriving an accurate growth rate projection.
  • New Acquisitions, Collaborations, or Partnerships: We keep a close watch on any new acquisitions, collaborations, or partnerships within the industry. These developments can have a significant impact on market dynamics and competitiveness.
  • Macro and Micro Factors Analysis:A thorough examination of both macro-level factors (e.g., economic trends, regulatory changes) and micro-level factors (e.g., technological advancements, consumer preferences) that may influence the market during the forecast period.
  • End-User Sentiment Analysis: To understand the market from the end-user perspective, we conduct sentiment analysis. This involves assessing the sentiment, preferences, and feedback of the end-users, which can provide valuable insights into market trends.
  • Perspective of Primary Participants: Insights gathered directly from primary research participants play a crucial role in shaping our forecasts. Their perspectives and experiences provide valuable qualitative data.
  • Year-on-Year Growth Trend: We utilize a year-on-year growth trend based on historical market growth and expected future trends. This helps in formulating our growth projections, aligning them with the market’s historical performance.

Research process adopted by TNR involves multiple stages, including data collection, validation, quality checks, and presentation. It’s crucial that the data and information we provide add value to your existing market understanding and expertise. We have also established partnerships with business consulting, research, and survey organizations across regions and globally to collaborate on regional analysis and data validation, ensuring the highest level of accuracy and reliability in our reports.

 

 

Procure Comprehensive Study of

Global Mobile Gamma Cameras Market

Online Only

  • Online Access
  • Read Only File
  • Validity 3 Months
  • Print, Copy, Paste & Download
  • PPT, Excel
  • Cost-Free Report in the Next Update
$3300
Buy Now

Single User

  • Access to One User on One System
  • Read Only File
  • Validity 6 Months
  • Limited Print,Copy, Paste
  • PPT, Excel
  • Cost-Free Report in the Next Update
$4200
Buy Now

Multi User

  • Access to Fiver Users
  • PDF File
  • Validity 1 Year
  • Upto FivePrints
  • Cost-Free Report in the Next Update
  • PPT, Excel
$6000
Buy Now

Enterprise User

  • Access to Unlimited Users
  • PDF, PPT, Excel
  • Unlimited Validity, Prints&Downloads
  • 1 Hour Cost-Free & Dedicated Analyst Support
  • 10% Cost-Free Customization
  • Cost-Free Report Update Twice in a Year
  • Recommendations for Business Strategies
  • Authorization to Quote TNR, The Niche Research
$7300
Buy Now

Library Access

  • Online Access to Content Publications
  • Access Player Profiles Online
  • Get Immediate Access to Newly Added Content
  • Acquire 12 PDF Downloads
  • Acquire 5 Excel Data Sets
  • Gain Access to 290+ PDFs of Company Profiles
  • Round-the-clock Email and Phone Assistance
  • Dashboard Usage and Trends
  • Renewal & Upgrade Assistance
  • Assessing Customization Options and Alerts for New Reports
$10788
Buy Now
*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Why TNR The Niche Research?

  • Unwavering Commitment to Excellence

  • Veteran Team of Researchers

  • Accurate and Timely Insights

  • Ethical Practices and Customized Service

  • Uninterrupted Availability Around the Clock

Scroll to Top